Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or ...
Bristol Myers said about 5% to 7% of people with metastatic colorectal cancer have microsatellite instability-high or mismatch-repair-deficient tumors, adding that these patients are less likely to ...
The Food and Drug Administration said it was taking the action because studies found that the dye, also known as erythrosine, ...
After a momentous 2024, Culver City-based ImmunityBio Inc., the immunotherapy company founded and majority-owned by ...
Dr. Debu Tripathy breaks down the FDA approval of Enhertu in unresectable or metastatic HR-positive, HER2-low or -ultralow ...
With certain government data currently being withheld, removed, or restored but partially redacted on the websites of ...
The company, now based in North Beach, has lost more than $2 billion over 29 years. Its only approved drug, called roxadustat ...
Several key members of the Senate Finance Committee have reintroduced a bill that seeks to establish a Medicare coverage ...
CAR-T-cell therapy treated a girl with a rare childhood cancer, raising hopes for future recipients of the approach.
The pharma industry is delivering game-changing therapies with favorable regulatory support. Amid this backdrop, investors ...
A new bill filed in Florida seeks to ban additives in food products. Senate Bill 560 and its partner House Bill 595 would ...